FOXO Technologies Inc.

Aging, Seniorcare Bioscience & Disease AI, ML, Gen AI

Aging, Seniorcare Bioscience & Disease +1

@FOXO_Tech Website LinkedIn Minneapolis, Minnesota, USA

About FOXO Technologies Inc.

FOXO Technologies Inc. leverages AI-driven bioinformatics and microarray technologies to develop and commercialize epigenetic biomarkers of health and aging, focusing on longevity science and its applications in life insurance.

Business Information

Target Customers

enterprise life insurance companies healthcare providers

Industry Categories

Aging, Seniorcare Bioscience & Disease AI, ML, Gen AI

Business Model

Revenue Model B2B SaaS

Pricing Strategy Subscription-based with tiered pricing

Sales Channels direct sales, partnerships with insurance companies

Funding Timeline

Round	Date	Amount	Investors
Series A	Jun 03, 2025	$1.65M	Unknown

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions

SEC Filings Digest @USCorpFilings

Jun 04, 2025

$FOXO Equity Offerings: On June 3, 2025, FOXO Technologies Inc. entered a Securities Purchase Agreement to issue 1,650 shares of Series A Preferred Stock, aiming to raise $1,650,000 by June 4, 2025, with associated costs of $150,000. This is part of a three-phase closure plan

View on Twitter

Similar Startups

Fore Biotherapeutics

85% match

Fore Biotherapeutics is a biotechnology company focused on developing innovative therapies for patie...

Foxy AI

85% match

Foxy AI helps ambitious creators generate ultra-realistic pictures and videos with AI, enabling them...

Epicore Biosystems

84% match

Developing sweat-sensing wearables that provide real-time health insights through sweat analysis.

inductive_bio

84% match

A platform that accelerates the discovery of life-changing therapeutics using state-of-the-art AI mo...